Cargando…
The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
IL-32 is a pro-inflammatory cytokine expressed by several types of cancer cells and immune cells. Currently, no treatment targeting IL-32 is available, and its intracellular and exosomal localization make IL-32 less accessible to drugs. We previously showed that hypoxia promotes IL-32 expression thr...
Autores principales: | Kastnes, Martin, Aass, Kristin Roseth, Bouma, Siri Anshushaug, Årseth, Charlotte, Zahoor, Muhammad, Yurchenko, Mariia, Standal, Therese |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258340/ https://www.ncbi.nlm.nih.gov/pubmed/37313466 http://dx.doi.org/10.3389/fonc.2023.1197542 |
Ejemplares similares
-
IL-32 is induced by activation of toll-like receptors in multiple myeloma cells
por: Aass, Kristin Roseth, et al.
Publicado: (2023) -
Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival
por: Roseth Aass, Kristin, et al.
Publicado: (2022) -
Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells
por: Aass, Kristin Roseth, et al.
Publicado: (2021) -
Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
por: Aass, Kristin Roseth, et al.
Publicado: (2022) -
Cysteine Dioxygenase Regulates the Epithelial Morphogenesis of Mammary Gland via Cysteine Sulfinic Acid
por: Zhao, Jianjun, et al.
Publicado: (2019)